Dube Eric M
CIK 1763494
Transactions on file
18
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 20 | $853.20 | +13.9% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 7,165 | $299.1K | +16.3% | open → |
| 2026-04-15 | 2026-04-15 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 56,815 | $2.33M | +18.4% | open → |
| 2026-04-15 | 2026-04-13 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Grant | 64,000 | $0.00 | — | open → |
| 2025-01-23 | 2025-01-22 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 10,736 | $208.9K | +149.6% | open → |
| 2025-02-04 | 2025-01-31 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Grant | 130,000 | $0.00 | — | open → |
| 2025-02-04 | 2025-02-03 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 50,691 | $1.02M | +140.3% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 11,375 | $273.5K | +102.0% | open → |
| 2025-05-05 | 2025-05-05 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Sale | 18,924 | $398.4K | +130.7% | open → |
| 2025-05-05 | 2025-05-02 | TVTX Travere Therapeutics, Inc. | OfficerDirector CHIEF EXECUTIVE OFFICER | Exer. | 18,924 | — | — | open → |
| 2026-05-07 | 2026-05-06 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 22,500 | $988.9K | +10.5% | open → |
| 2026-05-07 | 2026-05-04 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 22,500 | $0.00 | — | open → |
| 2026-02-24 | 2026-02-20 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $1.81M | +61.4% | open → |
| 2026-02-24 | 2026-02-20 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 60,000 | $927.6K | +214.2% | open → |
| 2025-10-30 | 2025-10-29 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 27,128 | $817.1K | +61.3% | open → |
| 2025-10-30 | 2025-10-29 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 27,128 | $419.4K | +214.2% | open → |
| 2025-10-30 | 2025-10-28 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sale | 92,872 | $2.82M | +59.9% | open → |
| 2025-10-30 | 2025-10-28 | TVTX Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Exer. | 92,872 | $1.44M | +214.2% | open → |
